Pilot Study of the Relationship Between Histologic Progression and Hepatic Iron Concentration in Chronic Hepatitis C

Journal of Clinical Gastroenterology

Volumn 37, Issue 5, 2003, Pages 406-411

  Larson, Anne M ^a,d   Taylor, Shari L ^b   Bauermeister, Donald ^c   Rosoff Jr , Leonard ^c   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GI Pathology Partners   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Hemochromatosis; Hepatic iron concentration; Hepatic iron index; Natural history; Siderosis

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEGENERATION; DISEASE COURSE; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; IRON STORAGE; LIVER BIOPSY; LIVER NECROSIS; MALE; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; BIOPSY, NEEDLE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOCHROMATOSIS; HEMOSIDEROSIS; HEPATITIS C, CHRONIC; HUMANS; IRON; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 0142053801     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200311000-00012     Document Type: Article

References (35)

1. van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol. 1994;20:410-415.
2. Rubin RB, Barton AL, Banner BF, et al. Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis. 1995;13:223-238.
3. Kuhn LC, Hentze MW. Coordination of cellular iron metabolism by posttranscriptional gene regulation. J Inorg Biochem. 1992;47:183-195.
4. Kang JO, Slivka A, Slater G, et al. In vivo formation of hydroxyl radicals following intragastric administration of ferrous salt in rats. J Inorg Biochem. 1989;35:55-69.
5. Bacon BR, Tavill AS, Brittenham GM, et al. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest. 1983;71:429-439.
6. Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology. 1990;11:127-137.
7. Bonkovsky HL. Iron and the liver. Am J Med Sci. 1991;301:32-43.
8. Kowdley KV, Trainer TD, Saltzman JR, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology. 1997;113:1270-1277.
9. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. [see comments] Gastroenterology. 1992;102:2108-2113.
10. Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol. 1998;29:257-262.
11. Menghini G. One-second needle biopsy of the liver. Gastroenterology. 1958;35:190-199.
12. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-435.
13. Searle JW, Kerr JFR, Halliday JW, et al. Iron Storage Disease. In: MacSween RNM, Anthony P, Scheuer PJ, et al, eds. Pathology of the Liver, 3rd ed. Edinburgh: Churchill Livingstone; 1994.
14. Emond MJ, Bronner MP, Carlson TH, et al. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45:340-346.
15. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986;6:24-29.
16. Chapman RW, Morgan MY, Laulicht M, et al. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci. 1982;27:909-916.
17. Nanji AA. Apoptosis and alcoholic liver disease. Semin Liver Dis. 1998;18:187-190.
18. Felton C, Lustbader ED, Merten C, et al. Serum iron levels and response to hepatitis B virus. Proc Natl Acad Sci U S A. 1979;76:2438-2441.
19. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. [see comments] Hepatology. 1997;25:759-768.
20. Riggio O, Montagnese F, Fiore P, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol. 1997;92:1298-1301.
21. Arber N, Konikoff FM, Moshkowitz M, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci. 1994;39:2656-2659.
22. Farinati F, Cardin R, De Maria N, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995;22:449-456.
23. Tung BY, Kowdley KV. Iron and Viral Hepatitis. Viral Hepatitis Reviews. 1999;5:63-76.
24. Takikawa T, Hayashi H, Nishimura N, et al. Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus. J Gastroenterol. 1994;29:593-597.
25. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 1996;16:248-254.
26. Beinker NK, Voigt MD, Arendse M, et al. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol. 1996;25:633-638.
27. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 1995;108:1104-1109.
28. Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol. 1995;7:1203-1208.
29. Hayashi H, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994;89:986-988.
30. Tsai NC, Zuckerman E, Han SH, et al. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy. Am J Gastroenterol. 1997;92:1831-1834.
31. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. [see comments] Nat Genet. 1996;13:399-408.
32. Smith BC, Gorve J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology. 1998;27:1695-1699.
33. Whittington CA, Kowdley KV. Review article: haemochromatosis. Aliment Pharmacol Ther. 2002;16:1963-1975.
34. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825-832.
35. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334-1340.